Tumor News and Research

RSS

Using a new genetic technology to decipher intratumoral heterogeneity

Even within a single patient with cancer, there is a vast diversity of individual tumor cells, which display distinct behaviors related to growth, metastasis, and responses to chemotherapy.

12 Nov 2021

Targeting Shp2 as a cancer therapy may worsen the disease

In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyrosine phosphatase 2 or more briefly, Shp2.

10 Nov 2021

Whole genome sequencing for children with cancer provides accurate diagnosis

According to a new study, revealing the entire genetic code for each child diagnosed with cancer could unravel new treatment options.

10 Nov 2021

Experts identify novel mechanisms involved in macrophage polarization

Macrophages are important cells of the immune system with numerous beneficial functions. However, macrophages also aggravate common diseases.

8 Nov 2021

Research uncovers key component of cellular malfunction that contributes to tumor growth

Scientists have homed in on a crucial step within the sequence of chemical reactions that govern regulation of cell division, proliferation and death, and whose malfunction contributes to the growth of tumors.

3 Nov 2021

CHOP-led network aims to unlock the genetic mysteries behind pediatric brain tumors

Unlocking the genetic mysteries behind pediatric brain tumors is at the heart of the mission of the Center for Data Driven Discovery in Biomedicine (D3b) at Children's Hospital of Philadelphia.

3 Nov 2021

Study reveals what causes T cells to be non-responsive to immunotherapy

Non-small cell lung cancer is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset of immune cells called T cells, which are "exhausted" and have stopped working.

1 Nov 2021

SARS-CoV-2 virus may be able to infect the inner ear, study shows

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

1 Nov 2021

Cancer cells change their shape and migration modes more often, says research

Recent research from the Oregon State University shows how malignant cells change their shape and migration techniques to attack various tissues.

29 Oct 2021

Study provides novel insights into how cells move through the body

Recent research published in eLife revealed that cells can control their capability to migrate throughout the body with the help of a protein named fascin.

29 Oct 2021

Intussusceptive angiogenesis contributes to growth of daughter tumors in malignant melanoma

For the first time, researchers at the University of Gothenburg have shown that metastases in patients with malignant melanoma gain access to the circulatory system not only through the outgrowth of new blood vessel branches, but also an alternative process in which one blood vessel divide into two parallel vessels bylongitudinal splitting.

28 Oct 2021

Study offers novel therapeutic opportunities to prevent breast tumor recurrence

Researchers examined tumor cells that were resistant to the original treatment and identified molecular targets for therapies that could evade breast cancer recurrence.

28 Oct 2021

Research reveals how cancer cells thrive by exploiting genetic and cellular processes

Writing in EMBO reports, researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe how a pair of fundamental genetic and cellular processes are exploited by cancer cells to promote tumor survival and growth.

From UC San Diego 27 Oct 2021

Experts use photothermal nanofibers for the safe engineering of therapeutic cells

Ghent University’s concentrated on a technique for the safe engineering of therapeutic cells with photothermal nanofibers for the past decade.

26 Oct 2021

Cell-free DNA employed to identify measurable residual disease

Researchers demonstrated that cell-free DNA from CSF could be employed to examine MRD in children treated for the brain tumor medulloblastoma.

25 Oct 2021

MIT researchers discover new way to awaken the immune system to attack tumors

Immunotherapy is a promising strategy to treat cancer by stimulating the body's own immune system to destroy tumor cells, but it only works for a handful of cancers. MIT researchers have now discovered a new way to jump-start the immune system to attack tumors, which they hope could allow immunotherapy to be used against more types of cancer.

From Massachusetts Institute of Technology (MIT) 20 Oct 2021

Tumor News and Research

Using a new genetic technology to decipher intratumoral heterogeneity

Targeting Shp2 as a cancer therapy may worsen the disease

Whole genome sequencing for children with cancer provides accurate diagnosis

Experts identify novel mechanisms involved in macrophage polarization

Research uncovers key component of cellular malfunction that contributes to tumor growth

CHOP-led network aims to unlock the genetic mysteries behind pediatric brain tumors

Study reveals what causes T cells to be non-responsive to immunotherapy

SARS-CoV-2 virus may be able to infect the inner ear, study shows

Cancer cells change their shape and migration modes more often, says research

Study provides novel insights into how cells move through the body

Intussusceptive angiogenesis contributes to growth of daughter tumors in malignant melanoma

Study offers novel therapeutic opportunities to prevent breast tumor recurrence

Research reveals how cancer cells thrive by exploiting genetic and cellular processes

Experts use photothermal nanofibers for the safe engineering of therapeutic cells

Cell-free DNA employed to identify measurable residual disease

MIT researchers discover new way to awaken the immune system to attack tumors

Neuroinflammation protein associated with sex-specific survival differences in glioblastoma patients

High tumor-infiltrating lymphocytes could indicate a better chance of survival in esophageal cancer

Researchers develop chimeric exosomes that co-activate immune response and tumor microenvironment

Molecular atlas of small cell lung cancer reveals signatures of metastasis and immunosuppression

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics